Gregory Daniel, PhD, MPH, RPh, is a fellow at the Engelberg Center for Health Care Reform at Brookings and managing director for evidence development and innovation for the Engelberg Center.

Before coming to Brookings, Dr. Daniel was the vice president of government and academic research at HealthCore, Inc., a research subsidiary of WellPoint, Inc. At HealthCore, he led a division responsible for providing research services in the areas of pharmacoepidemiology, drug, vaccine, and biologic safety evaluations, comparative effectiveness research, and health economics and outcomes research. His research has utilized electronic health insurance claims data integrated with clinical data including laboratory results, electronic hospital data, paper-based and electronic medical record data, and registries. Dr. Daniel is a registered pharmacist and holds a PhD in Pharmaceutical Economics, Policy, and Outcomes Research with a minor in Epidemiology from the University of Arizona, an MPH specializing in biostatistics, an MS in Pharmaceutical Administration, and a BS in Pharmacy, all from Ohio State University.

Dr. Daniel oversees and provides strategic direction for the Engelberg Center’s evidence development and biomedical innovation portfolio, including developing practical policy strategies, with broad stake-holder support, for improving U.S. capabilities in the areas of medical product safety surveillance, comparative effectiveness research, and biomedical innovation.

Health, Corporate Finance, Innovation, Thought Leaders, Think Tanks, Brookings Institute, influential, Policy, Public Policy,